More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$3.66B
EPS
-0.31
P/E ratio
--
Price to sales
1.57
Dividend yield
--
Beta
0.826176
Previous close
$147.22
Today's open
$147.22
Day's range
$145.94 - $148.64
52 week range
$107 - $175.51
show more
CEO
Vivek Jain
Employees
15000
Headquarters
San Clemente, CA
Exchange
Nasdaq Global Select
Shares outstanding
24686660
Issue type
Common Stock
Healthcare
Medical Equipment & Supplies
ICU Medical to Participate at the Piper Sandler 37th Annual Healthcare Conference
SAN CLEMENTE, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference being held in New York, December 2-4, 2025. ICU Medical's fireside chat will be on Thursday, December 4, 2025 at 10:00 a.m. PT (1:00 p.m. ET). Company management will also be participating in one-on-one meetings on Thursday, December 4, 2025.
GlobeNewsWire • Nov 20, 2025

ICU Medical, Inc. (ICUI) Q3 2025 Earnings Call Transcript
ICU Medical, Inc. ( ICUI ) Q3 2025 Earnings Call November 6, 2025 4:30 PM EST Company Participants Vivek Jain - CEO & Chairman of the Board Brian Bonnell - CFO & Treasurer Conference Call Participants Deirdre Thomson - ICR Inc. Jayson Bedford - Raymond James & Associates, Inc., Research Division Brett Fishbin - KeyBanc Capital Markets Inc., Research Division Michael Matson - Needham & Company, LLC, Research Division Lawrence Solow - CJS Securities, Inc. Jason Bednar - Piper Sandler & Co., Research Division Presentation Operator Good afternoon, everyone, and welcome to ICU Medical's Third Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note that today's event is being recorded.
Seeking Alpha • Nov 7, 2025

ICU Medical Announces Third Quarter 2025 Results and Updates its Fiscal Year 2025 Guidance
SAN CLEMENTE, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended September 30, 2025.
GlobeNewsWire • Nov 6, 2025

ICU Medical (ICUI) Surpasses Q3 Earnings and Revenue Estimates
ICU Medical (ICUI) came out with quarterly earnings of $2.03 per share, beating the Zacks Consensus Estimate of $1.54 per share. This compares to earnings of $1.59 per share a year ago.
Zacks Investment Research • Nov 7, 2025

ICU Medical Announces Time of Third Quarter 2025 Earnings Conference Call
SAN CLEMENTE, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its third quarter 2025 earnings release and conference call.
GlobeNewsWire • Oct 23, 2025

ICU Medical, Inc. (ICUI) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
ICU Medical, Inc. (NASDAQ:ICUI ) Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 8:30 AM EDT Company Participants Vivek Jain - CEO & Chairman of the Board Presentation Unknown Analyst Did you give me the disclosure? Did you say anything more?
Seeking Alpha • Sep 10, 2025

FDA Identifies ICU Medical's Plum Duo Recall as Serious Type
ICUI faces an FDA recall of its Plum Duo Infusion System over software flaws, though devices remain in use, pending fixes.
Zacks Investment Research • Sep 1, 2025

ICU Medical to Participate in Upcoming Investor Conferences
SAN CLEMENTE, Calif., Aug. 21, 2025 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced its participation in the following investor conferences in September:
GlobeNewsWire • Aug 21, 2025

ICU Medical, Inc. (ICUI) Q2 2025 Earnings Call Transcript
ICU Medical, Inc. (NASDAQ:ICUI ) Q2 2025 Earnings Call August 7, 2025 4:30 PM ET Company Participants Brian Michael Bonnell - CFO & Treasurer Vivek Jain - CEO & Chairman of the Board Conference Call Participants Charles S. Strauzer - CJS Securities, Inc. Jayson Tyler Bedford - Raymond James & Associates, Inc., Research Division Michael Toomey - Jefferies LLC, Research Division Michael Stephen Matson - Needham & Company, LLC, Research Division William Korner - Unidentified Company John Mills - ICR Inc. Operator Good afternoon, everyone, and welcome to today's ICU Medical Second Quarter 2025 Earnings Conference Call.
Seeking Alpha • Aug 10, 2025

ICU Medical (ICUI) Q2 EPS Jumps 40%
ICU Medical (ICUI 2.40%), a medical device company specializing in infusion therapy and related products, released its second quarter results on August 7, 2025. The most important news from the report was a significant earnings per share (EPS) beat, with adjusted EPS of $2.10 (Non-GAAP) compared to analyst expectations of $1.50, a positive difference of 40.0% (Non-GAAP).
The Motley Fool • Aug 8, 2025

¹ Disclosures

Open an M1 investment account to buy and sell ICU Medical Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.